FDA Ends Added Surveillance of Imports From Tianjin Port
The Food and Drug Administration ended its increased surveillance procedures for "FDA-regulated products imported from the industrial center Binhai New Area in Tianjin, China, and Xiditou Township of Beichen District in Tianjin, China," CBP said in a CSMS message (here).…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
"FDA has returned to routine surveillance of FDA-regulated products from this region." The FDA increased the surveillance after a major explosion at a Chinese port caused chemical contamination risks for goods from that area (see 1512230069).